245 related articles for article (PubMed ID: 30988330)
1. Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network.
Hellwege JN; Stallings S; Torstenson ES; Carroll R; Borthwick KM; Brilliant MH; Crosslin D; Gordon A; Hripcsak G; Jarvik GP; Linneman JG; Devi P; Peissig PL; Sleiman PAM; Hakonarson H; Ritchie MD; Verma SS; Shang N; Denny JC; Roden DM; Velez Edwards DR; Edwards TL
Sci Rep; 2019 Apr; 9(1):6077. PubMed ID: 30988330
[TBL] [Abstract][Full Text] [Related]
2. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
Na R; Helfand BT; Chen H; Conran CA; Crawford SE; Hayward SW; Tammela TLJ; Hoffman-Bolton J; Zheng SL; Walsh PC; Schleutker J; Platz EA; Isaacs WB; Xu J
Prostate; 2017 Aug; 77(11):1213-1220. PubMed ID: 28656603
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk.
Li W; Klein RJ
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):492-498. PubMed ID: 33219367
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas.
Yue L; Wang T; Ge Y; Ge M; Zhang C; Hou Q; Wang W; Tian H; Ren B; Du B; Zhang W
Prostate; 2019 Feb; 79(3):312-319. PubMed ID: 30450670
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
Qian X; Xu D; Liu H; Lin X; Yu Y; Kang J; Sheng X; Xu J; Zheng S; Xu D; Qi J
Aging Male; 2017 Dec; 20(4):250-256. PubMed ID: 28787260
[TBL] [Abstract][Full Text] [Related]
6. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
[TBL] [Abstract][Full Text] [Related]
7. LILRA3 is associated with benign prostatic hyperplasia risk in a Chinese Population.
Jiao Y; Wang L; Gu X; Tao S; Tian L; Na R; Chen Z; Kang J; Zheng SL; Xu J; Sun J; Qi J
Int J Mol Sci; 2013 Apr; 14(5):8832-40. PubMed ID: 23615473
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
[TBL] [Abstract][Full Text] [Related]
9. Glutathione S-transferase gene variants and risk of benign prostate hyperplasia in a North Indian population.
Konwar R; Manchanda PK; Chaudhary P; Nayak VL; Singh V; Bid HK
Asian Pac J Cancer Prev; 2010; 11(2):365-70. PubMed ID: 20843117
[TBL] [Abstract][Full Text] [Related]
10. Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia.
Pang Y; Li H; Gong Y; Jing S; Peng C; Liu W; Zhao Y; Wang H; Kaushik D; Rodriguez R; Wang Z
Oncol Rep; 2019 Apr; 41(4):2491-2501. PubMed ID: 30816510
[TBL] [Abstract][Full Text] [Related]
11. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
Salam MT; Ursin G; Skinner EC; Dessissa T; Reichardt JK
Urol Oncol; 2005; 23(4):246-53. PubMed ID: 16018939
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.
Yoo KH; Kim SK; Chung JH; Chang SG
Asian J Androl; 2010 Sep; 12(5):690-6. PubMed ID: 20562898
[TBL] [Abstract][Full Text] [Related]
13. CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
Madigan MP; Gao YT; Deng J; Pfeiffer RM; Chang BL; Zheng S; Meyers DA; Stanczyk FZ; Xu J; Hsing AW
Int J Cancer; 2003 Nov; 107(2):271-5. PubMed ID: 12949806
[TBL] [Abstract][Full Text] [Related]
14. The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS-BPH).
Chen ZP; Yan Y; Chen CJ; Li M; Chen C; Zhao SC; Song T; Liu T; Zou CH; Xu Q; Li X
Andrology; 2018 Jul; 6(4):568-578. PubMed ID: 29873201
[TBL] [Abstract][Full Text] [Related]
15. Null genotypes at the GSTM1 and GSTT1 genes and the risk of benign prostatic hyperplasia: a case-control study and a meta-analysis.
Choubey VK; Sankhwar SN; Tewari R; Sankhwar P; Singh BP; Rajender S
Prostate; 2013 Jan; 73(2):146-52. PubMed ID: 22692893
[TBL] [Abstract][Full Text] [Related]
16. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
[TBL] [Abstract][Full Text] [Related]
17. Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.
Nikolić ZZ; Branković AS; Savić-Pavićević DL; Preković SM; Vukotić VD; Cerović SJ; Filipović NN; Tomović SM; Romac SP; Brajušković GN
Clin Transl Sci; 2014 Aug; 7(4):307-13. PubMed ID: 24422606
[TBL] [Abstract][Full Text] [Related]
18. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
[TBL] [Abstract][Full Text] [Related]
19. Genetic susceptibility of benign prostatic hyperplasia.
Sanda MG; Beaty TH; Stutzman RE; Childs B; Walsh PC
J Urol; 1994 Jul; 152(1):115-9. PubMed ID: 7515446
[TBL] [Abstract][Full Text] [Related]
20. Genetic association between PSA-158G/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis.
Su XJ; Zeng XT; Fang C; Liu TZ; Wang XH
Oncotarget; 2017 May; 8(20):33953-33960. PubMed ID: 28430620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
